NanoString Technologies | NSTG - Операционный доход



Операционный доход Изменить Дата
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 10.2M 66.1M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.13B 217M 2026-06
Illumina USD 239M 17M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD 148M 122.52M 2026-03